The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
dc.contributor.author | Zhang, Min | |
dc.contributor.author | Wang, Shuqiang | |
dc.contributor.author | Wilffert, Bob | |
dc.contributor.author | Tong, Rongsheng | |
dc.contributor.author | van Soolingen, Dick | |
dc.contributor.author | van den Hof, Susan | |
dc.contributor.author | Alffenaar, Jan-Willem | |
dc.date.accessioned | 2018-08-03T09:40:26Z | |
dc.date.available | 2018-08-03T09:40:26Z | |
dc.date.issued | 2018-07-26 | |
dc.identifier.citation | The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis 2018 British Journal of Clinical Pharmacology | en |
dc.identifier.issn | 03065251 | |
dc.identifier.doi | 10.1111/bcp.13722 | |
dc.identifier.uri | http://hdl.handle.net/10029/622109 | |
dc.relation.url | http://doi.wiley.com/10.1111/bcp.13722 | en |
dc.rights | info:eu-repo/semantics/closedAccess | en |
dc.title | The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis | |
dc.type | Article | en |
dc.identifier.journal | Br J Clin Pharmacol 2018; 84(12):2747-60 | en |
dc.contributor.institution | Department of Pharmacy; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital; Chengdu China | |
dc.contributor.institution | University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology; Groningen The Netherlands | |
dc.contributor.institution | University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology; Groningen The Netherlands | |
dc.contributor.institution | Department of Pharmacy; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital; Chengdu China | |
dc.contributor.institution | Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Medical Microbiology; Radboud University Medical Centre; Nijmegen The Netherlands | |
dc.contributor.institution | KNCV Tuberculosis Foundation; The Hague The Netherlands | |
dc.contributor.institution | University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology; Groningen The Netherlands |